Symmetry Surgical (FRA:RZV) Debt-to-EBITDA : 4.46 (As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is Symmetry Surgical Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Symmetry Surgical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2014 was €0.4 Mil. Symmetry Surgical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2014 was €132.4 Mil. Symmetry Surgical's annualized EBITDA for the quarter that ended in Sep. 2014 was €29.8 Mil. Symmetry Surgical's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2014 was 4.46.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Symmetry Surgical's Debt-to-EBITDA or its related term are showing as below:

FRA:RZV' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0 Med: 0 Max: 6.86
Current: 6.86

During the past 13 years, the highest Debt-to-EBITDA Ratio of Symmetry Surgical was 6.86. The lowest was 0.00. And the median was 0.00.

FRA:RZV's Debt-to-EBITDA is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.26 vs FRA:RZV: 6.86

Symmetry Surgical Debt-to-EBITDA Historical Data

The historical data trend for Symmetry Surgical's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Symmetry Surgical Debt-to-EBITDA Chart

Symmetry Surgical Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Debt-to-EBITDA

Get a 7-Day Free Trial

1.62

1.96

9.41

3.64

-15.85

Symmetry Surgical Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Debt-to-EBITDA	Get a 7-Day Free Trial															-1.29	27.12	4.35	12.31	4.46

Competitive Comparison of Symmetry Surgical's Debt-to-EBITDA

For the Medical Devices subindustry, Symmetry Surgical's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Symmetry Surgical's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Symmetry Surgical's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Symmetry Surgical's Debt-to-EBITDA falls into.

Symmetry Surgical Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Symmetry Surgical's Debt-to-EBITDA for the fiscal year that ended in Dec. 2013 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(5.107	+	121.49)	/	-7.988
	=	-15.85

Symmetry Surgical's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2014 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.393	+	132.357)	/	29.784
	=	4.46

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2014) EBITDA data.

Symmetry Surgical (FRA:RZV) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Symmetry Surgical Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Symmetry Surgical's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Symmetry Surgical (FRA:RZV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Symmetry Surgical Inc (FRA:RZV) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.symmetrymedical.com

Symmetry Medical, Inc., is a Delaware corporation incorporated on July 25, 1996. It is a source of medical device products. The Company provides medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry and other medical device markets. It also manufactures specialized non-healthcare products, mainly in the aerospace industry. It operates in two reportable segments namely Original Equipment Manufacturer (OEM) Solutions and Symmetry Surgical. Its main products produced in the OEM Solutions segment include: implants, including forged, cast and machined products for the global orthopedic device market; instruments used in the placement and removal of orthopedic implants and in other surgical procedures; cases, including plastic, metal and hybrid cases used to organize, secure and transport medical devices for orthopedic, endoscopy, dental and other surgical procedures; and other specialized products for the aerospace market. Symmetry Surgical is its new business segment. It arose from the integration of the Codman and Olsen Medical lines of surgical instruments with its Company's already existing hospital direct business, Specialty Surgical Instrumentation (SSI). Symmetry Surgical, which is headquartered in Nashville, Tennessee offers reusable stainless steel and titanium surgical hand-held instruments and retractor systems, sterile disposable surgical products, and sterilization containers. These products are used in the surgical specialties of spine, general/obstetrics/gynecology, microsurgery/neurosurgery, orthopedics, and laparoscopy, cardiovascular, thoracic and general surgery in the hospital setting as well as surgery centers and in select physician offices. The Company's OEM Solutions segment has manufacturing facilities in the U.S., United Kingdom, France, Ireland and Malaysia. The Company's subject to federal, state and local environmental laws and regulations governing the emission, discharge, use, storage and disposal of hazardous materials and the remediation of contamination associated with the release of these materials at our facilities and at off-site disposal locations.